Eczema Clinical Trial - Paraffin Bath Therapy for Chronic Hand Eczema

Status Completed

Clinical Trial Summary

Objective: Chronic Hand eczema (CHE) is a common inflammatory skin disease has a major medical psychological and socio‐economic implications that affect quality of life (QoL)and work ability. This study, the first randomized controlled trial that will be conducted to evaluate the effect of paraffin bath therapy (PBT) in the treatment of CHE.

Clinical Trial Description

Design: The study design is a randomized controlled trial with measures at pre-and post-intervention.

Subjects: Sixty patients with moderate to severe Chronic Hand eczema (CHE) will participate in the study. They will be classified randomly into two groups of equal number; paraffin group and the control group.

Interventions: Paraffin group will receive Paraffin bath therapy for 5 days per week for 12 weeks in addition to routine skin care program while the control group will receive routine skin care program.

Outcome Measures:

Objective SCORing Atopic Dermatitis, subjective item score and dermatology life quality index (DLQI) will be assessed before, at 6th week and at 12th week of treatment. ;

Study Design

Related Conditions & MeSH terms

Eczema

Clinical Trial Details

NCT number	NCT04510961
Study type	Interventional
Source	Cairo University
Contact
Status	Completed
Phase	N/A
Start date	January 10, 2019
Completion date	January 25, 2020

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01257061` - Effectiveness of Clemastine Fumarate + Dexamethasone Compared to Dexchlorpheniramine Maleate in Eczema Treatment	Phase 3
Completed	`NCT03563066` - Effect of Benralizumab in Atopic Dermatitis	Phase 2
Withdrawn	`NCT03089476` - Evaluating Skin Barrier Dysfunction in Infants at High Risk of Atopy	N/A
Recruiting	`NCT04818138` - BROadband vs Narrowband photoTherapy for Eczema Trial Nested in the CACTI Cohort	N/A
Recruiting	`NCT05439577` - A Multicentre Study to Explore the Efficacy and Safety of Mucopolysaccharide Polysulfate Cream in Patients With Eczema
Completed	`NCT02916888` - A Study Comparing the Quality of Life of Patients in the Treatment of Eczema by Pediatric Generalists and Specialists	N/A
Completed	`NCT02075632` - Study to Evaluate Product Duration of Use Experience With Alclometasone Dipropionate Cream	Phase 2
Completed	`NCT00143819` - Neuroskin Forte for Dry Skin Relief in Eczema and Psoriasis	Phase 2
Recruiting	`NCT01631617` - Effects of Treatments on Atopic Dermatitis	Phase 2
Not yet recruiting	`NCT04520308` - An Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic Dermatitis	Phase 4
Completed	`NCT04358224` - The Utility of Functionally Relevant Signature Genes in Assessing the Clinical Outcomes of Dupilumab Treatment	Phase 4
Recruiting	`NCT03340155` - Mechanisms of Action of Photo(Chemo)Therapy in Skin Diseases	N/A
Completed	`NCT04023084` - Response of Children With Atopic Dermatitis (Eczema) to Eucrisa	Phase 4
Completed	`NCT03720470` - Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy	Phase 3
Completed	`NCT05583019` - Atopic Dermatitis With Accelerometry and Polysomnography (ADAP)
Completed	`NCT03293030` - Immunogenetic Profiling of Dupilumab for the Treatment of Atopic Dermatitis	Phase 4
Completed	`NCT02002871` - Blue Light for Treating Eczema	N/A
Completed	`NCT01420705` - Bacille Calmette-Guérin (BCG) Vaccine and Atopy	N/A
Recruiting	`NCT01012453` - A Randomised Clinical Trial in a Population of Health Care Workers With Hand Eczema	N/A
Completed	`NCT00375713` - Randomized Phase III Study to Evaluate the Efficacy and Safety of Xyzal® (Levocetirizine) vs Zyrtec® (Cetirizine) in Subjects With Dermatitis and Eczema	Phase 3